To investigate the impact of tumour volume, hypoxia and cancer stem cell (CSC) marker expression on outcome of patients with locally advanced head and neck squamous cell carcinoma (HNSCC) after primary radiochemotherapy.
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Material and Methods:
In this retrospective multicentre study, 160 patients with squamous cell carcinoma of the oral cavity, oropharynx and hypopharynx were included. All patients received primary cisplatin-based radiochemotherapy (RCT) between 2005 and 2011. Their median follow-up was about 26 months. Primary and nodal gross tumour volume (GTV) segmentations were performed centrally in the computer tomography-based radiation treatment plans. HPV status (p16 overexpression) and CD44 expression were analysed by immunohistochemistry. Gene expression analysis was performed for hypoxia-associated genes and the potential CSC marker SLC3A2. Results of the biomarker analyses, clinical parameters and tumour volume were correlated with the clinical outcome. Primary endpoint was loco-regional control (LRC). Secondary endpoints were distant metastases (DM) and overall survival (OS).
Results:
In univariate analysis, tumour volume, HPV status and CSC marker expression were significantly associated with LRC (tumour volume: HR 1.51, p=0.02; HPV: HR 0.30, p=0.02; CD44: HR 2.30, p=0.04; SLC3A2: HR 2.08, p=0.01). Interestingly, hypoxia showed a significant association with LRC in small tumours only (HR 9.26, p=0.04) . Multivariate Cox regression analysis including HPV status, tumour localisation, stage, smoking status, tumour volume and hypoxia or the respective CSC marker showed a significant effect of the tumour volume (HR: 1.6-1.8, p<0.01), SLC3A2 (HR 2.03, p=0.02) or CD44 (HR 2.52, p=0.04) on LRC. Tumour hypoxia also reached borderline significance in small tumours (HR 7.86, p=0.06) . Interestingly, the tumour volume was an independent variable in all Cox models, a high tumour volume was significantly associated with poor LRC. Tumour volume and CSC marker expression also showed a negative prognostic impact on the secondary endpoints DM and OS.
